stopping and restarting glp 1 GLP-1 Weight Regain After Ozempic: What to Expect Stopping GLP-1 Drugs May Raise

doi: 10.1183/09031936.02.01582001 112 ZanconatoSScolloMZaramellaCLandiLZacchelloFBaraldiE

The 2026 regulatory developments The status of several peptides shifted recently

In early clinical studies, retatrutide has delivered unprecedented weight lossup to 24.2% of body weight in less than a yearwhile also improving blood pressure, cholesterol, and liver fat content

Notably, these effects were not mimicked by E alone, which failed to rescue cycle perturbations and had a discernible uterotrophic action, but were replicated, in terms of reversal of irregularities of the ovarian cycle, by GLP1 alone, which nonetheless did not elevate LH levels